Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.

Daniel Rodriguez,Sarika Kapoor,Ilka Edenhofer,Stephan Segerer,Meliana Riwanto,Anja Kipar,Ming Yang,Changlin Mei,Rudolf P. Wüthrich

Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.

2015

Daniel Rodriguez
Sarika Kapoor
Ilka Edenhofer
Stephan Segerer
Meliana Riwanto
Anja Kipar
Ming Yang
Changlin Mei
Rudolf P. Wüthrich

Background/Aims: Dapagliflozin (DAPA) is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) which induces glucosuria and osmotic diuresis. The th

Keywords:

Cotransporter
Dapagliflozin
Endocrinology
Internal medicine
Renal function
Diuresis
Sodium/Glucose Cotransporter 2
Polycystic kidney disease
Kidney
Glycosuria
Medicine
SprD
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations